
                                SEQUENCE LISTING

<110> NOVARTIS AG

<120> POSITIVELY CHARGED SPECIES AS BINDING
  REAGENTS OF OLIGOMERS

<130> 22300-2111440 

<140> Not Yet Assigned    
<141> Concurrently Herewith            

<160> 98

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 1
Lys Lys Lys Phe Lys Phe
 1               5      


<210> 2
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 2
Lys Lys Lys Trp Lys Trp
 1               5      


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 3
Lys Lys Lys Leu Lys Leu
 1               5      


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 4
Lys Lys Lys Lys Lys Lys
 1               5      


<210> 5
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 5
Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys
 1               5                  10          


<210> 6
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 6
Lys Phe Tyr Leu Tyr Ala Ile Asp Thr His Arg Met
 1               5                  10          


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 7
Lys Ile Ile Lys Trp Gly Ile Phe Trp Met Gln Gly
 1               5                  10          


<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 8
Asn Phe Phe Lys Lys Phe Arg Phe Thr Phe Thr Met
 1               5                  10          


<210> 9
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 6
<223> Xaa = N-(methylstilbene)glycine

<400> 9
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 10
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = N-(4-aminoethyl)glycine

<221> VARIANT        
<222> 4, 6
<223> N-benzylglycine

<400> 10
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 11
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 6
<223> N-(octyl)glycine

<400> 11
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 12
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = N-(4-guanidinobutyl)glycine

<221> VARIANT        
<222> 4, 6
<223> N-benzylglycine

<400> 12
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 13
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5, 7, 8, 9, 11
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 6, 10, 12
<223> Xaa = N-benzylglycine

<400> 13
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5                  10          


<210> 14
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5, 7, 8, 9, 11, 13, 14, 15, 17
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 6, 10, 12, 16, 18
<223> Xaa = N-benzylglycine

<400> 14
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5                  10                  15      
Xaa Xaa
        


<210> 15
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 6
<223> Xaa = N-benzylglycine

<400> 15
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 16
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 4, 5, 6
<223> Xaa = N-(4-aminobutyl)glycine

<400> 16
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 4, 5, 6, 7
<223> Xaa = N-(4-aminobutyl)glycine

<400> 17
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 4, 6
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 3, 5, 7
<223> Xaa = N-benzylglycine

<400> 18
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3, 5, 7
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 2, 4, 6
<223> Xaa = N-benzylglycine

<400> 19
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 20
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 7
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 5, 6
<223> Xaa = N-benzylglycine

<400> 20
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 21
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3, 5
<223> Xaa = N-(2-methoxyethyl)glycine

<221> VARIANT        
<222> 2, 4, 6
<223> Xaa = N-benzylglycine

<400> 21
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 4, 5, 6, 7
<223> Xaa = N-(2-carboxyethyl)glycine

<400> 22
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 23
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 5, 6
<223> Xaa = N-(2-carboxyethyl)glycine

<221> VARIANT        
<222> 3, 4, 7
<223> Xaa = N-benzylglycine

<400> 23
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 24
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3, 5, 7
<223> Xaa = N-(2-carboxyethyl)glycine

<221> VARIANT        
<222> 2, 4, 6
<223> Xaa = N-benzylglycine

<400> 24
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 25
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 7
<223> Xaa = N-(2-carboxyethyl)glycine

<221> VARIANT        
<222> 4, 5, 6
<223> Xaa = N-benzylglycine


<400> 25
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 26
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 5, 6
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 3, 4, 7
<223> Xaa = N-(2-carboxyethyl)glycine

<400> 26
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 27
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3, 5, 7
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 2, 4, 6
<223> Xaa = N-(2-carboxyethyl)glycine

<400> 27
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 28
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 7
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 4, 5, 6
<223> Xaa = N-(2-carboxyethyl)glycine

<400> 28
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 29
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = N-(2-carboxyethyl)glycine

<221> VARIANT        
<222> 4, 6
<223> Xaa = N-benzylglycine

<400> 29
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 30
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 30
Asp Asp Asp Asp Asp Asp
 1               5      


<210> 31
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 31
His His His His His His
 1               5      


<210> 32
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 32
Ala Ala Lys Lys Ala Ala
 1               5      


<210> 33
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 33
Ala Ala Lys Lys Lys Ala
 1               5      


<210> 34
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 34
Ala Lys Lys Lys Lys Ala
 1               5      


<210> 35
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 35
Ala Lys Lys Lys Lys Lys
 1               5      


<210> 36
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 36
Phe Lys Phe Lys Lys Lys
 1               5      


<210> 37
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 2, 3, 5
<223> Xaa = D-Lysine

<221> VARIANT        
<222> 4, 6
<223> Xaa = D-Phenylalanine

<400> 37
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 38
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 38
Phe Lys Phe Ser Leu Phe Ser Gly
 1               5              


<210> 39
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 39
Asp Phe Lys Leu Asn Phe Lys Phe
 1               5              


<210> 40
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 40
Phe Lys Phe Asn Leu Phe Ser Gly
 1               5              

     
<210> 41
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 41
Tyr Lys Tyr Lys Lys Lys
 1               5      


<210> 42
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 42
Lys Lys Phe Lys Lys Phe
 1               5      


<210> 43
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 43
Lys Phe Lys Lys Lys Phe
 1               5      


<210> 44
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 44
Lys Ile Gly Val Val Arg
 1               5      


<210> 45
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 45
Ala Lys Val Lys Lys Lys
 1               5      


<210> 46
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 46
Ala Lys Phe Lys Lys Lys
 1               5      


<210> 47
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 47
Arg Gly Arg Glu Arg Phe Glu Met Phe Arg
 1               5                  10  


<210> 48
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 48
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg
 1               5                  10      


<210> 49
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 49
Phe Phe Phe Lys Phe Lys Lys Lys
 1               5              


<210> 50
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 50
Phe Phe Phe Phe Phe Lys Phe Lys Lys Lys
 1               5                  10                   


<210> 51
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 51
Phe Phe Phe Lys Lys Lys
 1               5      


<210> 52
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 52
Phe Phe Phe Phe Lys Lys
 1               5      


<210> 53
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 2, 4, 5, 6
<223> Xaa = the alpha amino acid 2, 4-diaminobutanoic acid

<400> 53
Phe Xaa Phe Xaa Xaa Xaa
 1               5      


<210> 54
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 2, 4, 5, 6
<223> Xaa = the delta amino acid 2, 5-diaminopentanoic acid

<400> 54
Phe Xaa Phe Xaa Xaa Xaa
 1               5      


<210> 55
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = 2-(2-aminoethylamino)acetyl

<400> 55
Xaa Lys Lys Phe Lys Phe
 1               5      


<210> 56
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = (2-triethylamino)acetyl

<400> 56
Xaa Lys Lys Phe Lys Phe
 1               5        


<210> 57
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = (2-((2-(dimethylamino)ethyl)(dimethyl)amino)acetyl

<400> 57
Xaa Lys Lys Phe Lys Phe
 1               5      


<210> 58
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 2, 3, 5
<223> Xaa = 4-aminomethylphenylalanine

<400> 58
Ala Xaa Xaa Phe Xaa Ala
 1               5      


<210> 59
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3
<223> Xaa = thienylalanine (Thi)

<400> 59
Xaa Lys Xaa Lys Lys Lys
 1               5      


<210> 60
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 4, 6
<223> Xaa = 4-chlorophenylalanine (4-Cl-F)

<400> 60
Lys Lys Lys Xaa Lys Xaa
 1               5      


<210> 61
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 4, 6
<223> Xaa = 4-nitrophenylalanine (4-NO2-F)

<400> 61
Lys Lys Lys Xaa Lys Xaa
 1               5      



<210> 62
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3
<223> Xaa = pentafluorophenylalanine (F5Phe)

<400> 62
Xaa Lys Xaa Lys Lys Lys
 1               5      


<210> 63
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3
<223> Xaa = 2-naphthylalanine (Nap)

<400> 63
Xaa Lys Xaa Lys Lys Lys
 1               5      


<210> 64
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3
<223> Xaa = p-biphenylalanine (Bip)

<400> 64
Xaa Lys Xaa Lys Lys Lys
 1               5      


<210> 65
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3
<223> Xaa = styrylalanine (Sty)

<400> 65
Xaa Lys Xaa Lys Lys Lys
 1               5      


<210> 66
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 3
<223> Xaa = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic)

<400> 66
Xaa Lys Xaa Lys Lys Lys
 1               5      


<210> 67
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 67
Met Lys Phe Met Lys Met His Asn Lys Lys Arg Tyr
 1               5                  10          


<210> 68
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 68
Leu Thr Ala Val Lys Lys Val Lys Ala Pro Thr Arg
 1               5                  10          


<210> 69
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 69
Leu Ile Pro Ile Arg Lys Lys Tyr Phe Phe Lys Leu
 1               5                  10          


<210> 70
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 70
Lys Leu Ser Leu Ile Trp Leu His Thr His Trp His
 1               5                  10          


<210> 71
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 71
Ile Arg Tyr Val Thr His Gln Tyr Ile Leu Trp Pro
 1               5                  10          


<210> 72
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 72
Tyr Asn Lys Ile Gly Val Val Arg Leu Phe Ser Glu
 1               5                  10          


<210> 73
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 73
Tyr Arg His Arg Trp Glu Val Met Leu Trp Trp Pro
 1               5                  10          


<210> 74
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 74
Trp Ala Val Lys Leu Phe Thr Phe Phe Met Phe His
 1               5                  10          


<210> 75
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 75
Tyr Gln Ser Trp Trp Phe Phe Tyr Phe Lys Leu Ala
 1               5                  10          


<210> 76
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 76
Trp Trp Tyr Lys Leu Val Ala Thr His Leu Tyr Gly
 1               5                  10          


<210> 77
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 77
Gln Thr Leu Ser Leu His Phe Gln Thr Arg Pro Pro
 1               5                  10          


<210> 78
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 78
Thr Arg Leu Ala Met Gln Tyr Val Gly Tyr Phe Trp
 1               5                  10          


<210> 79
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 79
Arg Tyr Trp Tyr Arg His Trp Ser Gln His Asp Asn
 1               5                  10          


<210> 80
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 80
Ala Gln Tyr Ile Met Phe Lys Val Phe Tyr Leu Ser
 1               5                  10          


<210> 81
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 81
Thr Gly Ile Arg Ile Tyr Ser Trp Lys Met Trp Leu
 1               5                  10          


<210> 82
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 82
Ser Arg Tyr Leu Met Tyr Val Asn Ile Ile Tyr Ile
 1               5                  10          


<210> 83
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 83
Arg Tyr Trp Met Asn Ala Phe Tyr Ser Pro Met Trp
 1               5                  10          


<210> 84
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 84
Asn Phe Tyr Thr Tyr Lys Leu Ala Tyr Met Gln Met
 1               5                  10          


<210> 85
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 85
Met Gly Tyr Ser Ser Gly Tyr Trp Ser Arg Gln Val
 1               5                  10          


<210> 86
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 86
Tyr Phe Tyr Met Lys Leu Leu Trp Thr Lys Glu Arg
 1               5                  10          


<210> 87
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 87
Arg Ile Met Tyr Leu Tyr His Arg Leu Gln His Thr
 1               5                  10          


<210> 88
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 88
Arg Trp Arg His Ser Ser Phe Tyr Pro Ile Trp Phe
 1               5                  10          


<210> 89
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 89
Gln Val Arg Ile Phe Thr Asn Val Glu Phe Lys His
 1               5                  10          


<210> 90
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<400> 90
Arg Tyr Leu His Trp Tyr Ala Val Ala Val Lys Val
 1               5                  10          


<210> 91
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = N-(2-aminoethyl)glycine

<221> VARIANT        
<222> 2
<223> Xaa = N-(2,2-diphenylethyl)glycine

<221> VARIANT        
<222> 3
<223> Xaa = 3-(2-oxopyrrolidin-1-yl)propyl)glycine

<221> VARIANT        
<222> 4
<223> Xaa = N-(3,4-difluorobenzyl)glycine

<221> VARIANT        
<222> 5
<223> Xaa = N-(2-methoxyethyl)glycine

<221> VARIANT        
<222> 6
<223> Xaa = N-tetrahydrofufurylglycine

<400> 91
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 92
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = N-allylglycine

<221> VARIANT        
<222> 2
<223> Xaa = N-(2-(4-hydroxyphenyl)ethyl)glycine

<221> VARIANT        
<222> 3
<223> Xaa = N-(cyclopropylmethyl)glycine

<221> VARIANT        
<222> 4
<223> Xaa = N-(cyclohexylmethyl)glycine

<221> VARIANT        
<222> 5
<223> Xaa = N-(4-carboxyethyl)glycine

<400> 92
Xaa Xaa Xaa Xaa Xaa
 1               5  


<210> 93
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = N-(4-methoxybenzyl)glycine

<221> VARIANT        
<222> 2
<223> Xaa = N-(3-furylmethyl)glycine

<221> VARIANT        
<222> 3
<223> Xaa = N-benzylglycine

<221> VARIANT        
<222> 4
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 5
<223> Xaa = N-(2-aminoethyl)glycine

<221> VARIANT        
<222> 6
<223> Xaa = N-(4-sulfamoylphenethyl)glycine

<400> 93
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 94
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = N-(piperidin-4-ylmethyl)glycine

<221> VARIANT        
<222> 2
<223> Xaa = N-(cyclopropylmethyl)glycine

<221> VARIANT        
<222> 3
<223> Xaa = N-(2-hydroxyethyl)glycine

<221> VARIANT        
<222> 4
<223> Xaa = N-(3,4-difluorobenzyl)glycine

<221> VARIANT        
<222> 5
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 6
<223> Xaa = N-(cyclohexylmethyl)glycine

<400> 94
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 95
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = N-(2-carboxyethyl)glycine

<221> VARIANT        
<222> 2
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 3
<223> Xaa = N-(2-(4-hydroxyphenyl)ethyl)glycine

<221> VARIANT        
<222> 4
<223> Xaa = N-(4-sulfamoylphenethyl)glycine

<221> VARIANT        
<222> 5
<223> Xaa = N-(2-methoxyethyl)glycine

<221> VARIANT        
<222> 6
<223> Xaa = N-(2-aminoethyl)glycine

<400> 95
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 96
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1, 4, 7, 10
<223> Xaa = N-(4-aminobutyl)glycine

<221> VARIANT        
<222> 2, 3, 5, 6, 8, 9, 11, 12
<223> Xaa = (S)-N-(1-phenethyl)glycine

<400> 96
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5                  10          


<210> 97
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = N-benzylglycine

<221> VARIANT        
<222> 2
<223> Xaa = N-(2-hydroxyethyl)glycine

<221> VARIANT        
<222> 3
<223> Xaa = N-(2,2-diphenylethyl)glycine

<221> VARIANT        
<222> 4
<223> Xaa = N-(4-carboxyethyl)glycine

<221> VARIANT        
<222> 5
<223> Xaa = N-tetrahydrofufurylglycine

<221> VARIANT        
<222> 6
<223> Xaa = N-(cyclopropylmethyl)glycine

<400> 97
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 98
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthesized Construct

<221> VARIANT        
<222> 1
<223> Xaa = acetylated phenylalanine

<221> VARIANT        
<222> 7, 8
<223> Xaa = aminohexanoic acid

<221> VARIANT        
<222> 9
<223> Xaa = cysteine with a C terminal amide

<400> 98
Xaa Lys Phe Lys Lys Lys Xaa Xaa Xaa
 1               5                  

